Spyre Therapeutics, Inc. (SYRE)

SEC filing

Spyre Therapeutics, Inc.

SYRE · CIK 1636282

4 · Oct 2, 2026 · Director, Chief Executive Officer Turtle Cameron sold 15K shares at $92.01/share ($1.4M)

Director, Chief Executive Officer Turtle Cameron sold 15K shares at $92.01/share ($1.4M)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.